An Observer-blind, Safety Study of GSK Biologicals' Haemophilus Influenzae and Streptococcus Pneumoniae Candidate Vaccine in Adults.

Trial Profile

An Observer-blind, Safety Study of GSK Biologicals' Haemophilus Influenzae and Streptococcus Pneumoniae Candidate Vaccine in Adults.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2015

At a glance

  • Drugs Haemophilus influenzae-pneumococcal vaccine; Hepatitis A-hepatitis B vaccine
  • Indications Hepatitis A; Hepatitis B; Influenza virus infections; Pneumococcal infections
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Feb 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 23 May 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
    • 05 Mar 2009 Planned initiation date changed from 1 Feb 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top